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http:WHAT THIS PAPER ADDS
This study provides an insight into the contemporary management of aorto-iliac aneurysms and of its early and
mid-term results.Introduction: The aim of this report was to analyse early and mid-term outcomes of endovascular treatment
(endovascular aneurysm repair, EVAR) for aorto-iliac aneurysms with the use of an iliac branch device (IBD).
Report: A total of 85 EVAR procedures with IBD were electively carried out in 81 patients between September
2007 and August 2012. Technical success was obtained in 98.7% of the cases. The mean follow-up duration was
20.4 months (SD  15.4). There was one IBD occlusion (1.2%). Estimated 48 months’ survival, freedom from re-
intervention and branch occlusion were 76.7%, 88.3% and 98%, respectively.
Conclusions: EVAR for aorto-iliac aneurysms using IBD is an effective procedure with low complication and re-
intervention rates at mid-term follow-up.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Keywords: Aorto-iliac aneurysm, Iliac branch endograftThe iliac branch device (IBD) has been proposed as an
effective total endovascular solution for common iliac artery
aneurysms (IAAs). However, most of the data come from
single-centre experiences collecting small series of
patients1e3 and few reports are available about the long-
term outcomes of this technique.4,5 The aim of this study
was to review our experience in the endovascular treat-
ment of aorto-iliac aneurysms with the use of IBDs.
REPORT
From September 2007 to August 2012, 99 patients with
aorto-iliac aneurysms underwent endovascular exclusion at
two Italian academic hospitals. A total of 85 IBDs were
implanted (71 Zenith Bifurcated Iliac sidebranch e ZBIS; 11
Zenith Helical Iliac sidebranch e ZHIS; and 3 bifurcated-
bifurcated e bif-bif conﬁguration, Cook, Bloomington, IN,
USA) in 81 anatomically feasible patients. Eighteen addi-
tional patients who received treatment different from IBD
(5 iliac sandwich, 3 multilayer stent and 10 internal iliac
artery embolisation procedures) were excluded from the
present analysis.
A total of 51 patients had IBD for unilateral common iliac
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//dx.doi.org/10.1016/j.ejvs.2013.02.017isolated iliac aneurysm, of whom two were treated with
a stand-alone IBD device. As many as 30 patients (37.1%)
presented bilateral CIA aneurysm. In four of them (4.9%),
a bilateral IBD exclusion was achieved. Out of the remaining
26 patients (32.1%), unilateral IBD was associated with
contralateral IAA embolisation in 17 (20.9%), while 9
patients (11.1%) underwent direct overstenting into the
external iliac artery (EIA) without any embolisation.
Ten patients (12.3%)with an ectatic hypogastricmain trunk,
presenting a landing zone between 10 and 14mm in diameter
and a minimum of 15 mm length, were treated with a large
balloon-expandable covered bridging stent (Large Diameter
Advanta V12, AtriumMedical, Hudson, NH, USA), 12 or 14mm
in diameter. Procedural technical success was achieved in 80
patients (98.7%) with no perioperative mortality. The unsuc-
cessful case was due to proximal IBD side-branch collapse,
probably related to the challenging anatomy of the iliac
bifurcation. An external iliac-to-hypogastric artery surgical
bypass was performed with restoration of the ﬂow and
without any postoperative complications. The mean hospi-
talisation time was 5 days (3).
During the ﬁrst 30 postoperative days, only one IBD
occlusion was observed. One patient underwent throm-
bectomy and ilio-femoral artery bypass due to external
endograft limb occlusion contralateral to IBD. In three
patients (3.7%), a distal type I IBD endoleak was detected at
the ﬁrst computed tomography (CT) scan. As in all these
cases a large covered stent was used in the internal iliac
side branch (Large Diameter Advanta V12, Atrium Medical,
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distal type I endoleak and ectatic hypogastric main trunk
was observed (Fisher’s exact test c2: 20.9; p ¼ 0.002). These
patients were conservatively managed and a strict surveil-
lance protocol was planned in order to monitor the sac
behaviour. At the moment, they are still under investigation
and no sac enlargement has been recorded.
Themean follow-up duration was 20.4months (SD 15.4).
Seven patients (8.6%) died due to non-aneurysm-related
causes with an estimated overall survival of 89.5% and
76.7% at 24 and 48 months, respectively (Fig. 1a). Aneurysm-
related deaths, conversions to open repair or aneurysm
ruptures did not occur. No additional IBD occlusion was
observed,with an estimated IBDpatencyof 98%at 48months.
Seven patients (8.6%) suffered from buttock claudication.
This symptom occurred in 6 out of 30 patients treated for
bilateral CIA aneurysms (20%) on the side of hypogastric
exclusion and did not improve during follow-up.Figure 1. a. KaplaneMeyer curve for cumulative survival, with numbe
intervals. b. KaplaneMeyer curve for freedom from any endoleak, wi
follow-up intervals. c. KaplaneMeyer curve for freedom from reinterv
different follow-up intervals.The remaining case was associated with the early IBD
occlusion. No ipsilateral buttock claudication was observed
in patients with a patent IBD in the follow-up.
Neither late proximal type I and III endoleak nor new
cases of distal type I IBD endoleak were detected with the
estimated freedom from any endoleak at 48 months being
88.3% (Fig. 1b). Three patients (3.7%) underwent
a secondary procedure during follow-up, in only one case
IBD-related. This patient revealed at the 3-year CT scan an
asymptomatic pre-occlusive thrombosis of the external IBD
segment, which was successfully treated with thrombolysis
and stenting. The estimated freedom from re-intervention
at 48 months was 88.3% (Fig. 1c).
DISCUSSION
In the last decade, a number of studies have assessed the
feasibility and safety of this novel endovascular tech-
nique.1e3 However, most series in the literature are basedr of patients at risk and standard error (SE) at different follow-up
th number of patients at risk and standard error (SE) at different
ention, with number of patients at risk and standard error (SE) at
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about the midterm outcome of this technique.4,5
In this series we reported our experience with IBD in
a selected group of patients achieving satisfactory early and
follow-up results, with low rates of peri-procedural
complications. The presence of an ectatic hypogastric
artery was signiﬁcantly associated with type Ib endoleak
development during follow-up.
As all these patients received the same kind of stent and
the endoleaks were located at the distal sealing zone in the
ectatic hypogastric main trunk in all the cases, a possible
explanation can be identiﬁed in a not-appropriate con-
formability of the stent under the pressure of dislodgement
forces that normally develop during the postoperative
period together with the aneurysm shrinkage process.
Based on our experience and in accordance with the
current literature, we can argue that probably the aneu-
rysmal involvement of the hypogastric artery might be
considered an actual limit to the applicability of the IBD
technique. In fact, even if technically feasible, both options
involving either the landing in one of the two main hypo-
gastric branches or the landing in the main hypogastric
trunk have been demonstrated to be associated with an
increased risk of complications and secondary procedures.
In conclusion, iliac branched endografts is an effective
technique for IIA preservation during EVAR, when used in
anatomically feasible patients. It offers a high technicalsuccess rate and a low incidence of complications in terms
of re-interventions, endoleaks and limb occlusions at early
and mid-term follow-up and may represent a valid tech-
nique in the case of bilateral iliac artery aneurysm.CONFLICT OF INTEREST/FUNDING
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